Incidence of Myocardial Infarction, Stroke, and Death in Patients With Age-Related Macular Degeneration Treated With Intravitreal Anti–Vascular Endothelial Growth Factor Therapy-Reference-Cited by-同舟云学术

Incidence of Myocardial Infarction, Stroke, and Death in Patients With Age-Related Macular Degeneration Treated With Intravitreal Anti–Vascular Endothelial Growth Factor Therapy

Published:2015-03 Issue:3 Volume:159 Page:557-564.e1
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Ng Wei Yan,Tan Gavin Siew Wei,Ong Peng-Guan,Cheng Ching-Yu,Cheung Carol Yim-Lui,Wong Doric Wen Kuan,Mathur Ranjana,Chow Khuan Yew,Wong Tien Yin,Cheung Gemmy Chui Ming

Publisher

Elsevier BV

Subject

Ophthalmology

Reference46 articles.

1. Clinical update: new treatments for age-related macular degeneration;Wong;Lancet,2007

2. Management of retinal vascular diseases: a patient-centric approach;Brand;Eye (Lond),2012

3. Clinical safety of ranibizumab in age-related macular degeneration;Schmidt-Erfurth;Expert Opin Drug Saf,2010

4. Emerging evidence concerning systemic safety of anti-VEGF agents–should ophthalmologists be concerned?;Lim;Am J Ophthalmol,2011

5. Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review;Schmucker;Br J Ophthalmol,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticles as drug delivery agents for managing diabetic retinopathy;Applications of Multifunctional Nanomaterials;2023

2. Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: A nationwide population‐based cohort study;PLOS ONE;2022-04-18

3. Increased mortality after intravitreal injections of anti-VEGF for neovascular AMD among patients with prior stroke or acute myocardial infarction;Eye;2021-03-02

4. Pseudophakic Cystoid Macular Oedema;Cataract Surgery;2021

5. Safety and clinical effectiveness of intravitreal administration of bevacizumab (Lumiere^®) in patients with neovascular age‑related macular degeneration;Experimental and Therapeutic Medicine;2020-10-09